PRINTER'S NO. 20
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
17
Session of
2017
INTRODUCED BY BURNS, MURT, DiGIROLAMO, DRISCOLL, GAINEY,
READSHAW, MOUL, NEILSON, MILLARD, DEASY, McNEILL, FARRY AND
FREEMAN, JANUARY 23, 2017
INTRODUCED AS NONCONTROVERSIAL RESOLUTION UNDER RULE 35,
JANUARY 23, 2017
A RESOLUTION
Requesting the Congress of the United States to urge the Food
and Drug Administration to reverse its directive allowing
OxyContin to be prescribed to children 11 to 16 years of age.
WHEREAS, Addiction is a primary, chronic and relapsing brain
disease that causes the addict to pursue reward or relief by
substance use and other behaviors; and
WHEREAS, According to the American Society of Addiction
Medicine, approximately 20.5 million Americans 12 years of age
or older had a substance use disorder in 2015; and
WHEREAS, Opioids are medications that relieve pain and
include the lawful prescription pain relievers oxycodone,
hydrocodone, codeine, morphine and fentanyl as well as the
illicit drug heroin; and
WHEREAS, In 2015, approximately 2 million Americans had a
substance use disorder involving prescription pain relievers,
while an additional 591,000 Americans had a substance use
disorder involving heroin; and
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17